XW04378
XW04378
is a valid billable ICD-10 procedure code for Introduction of Tabelecleucel Immunotherapy into Central Vein, Percutaneous Approach, New Technology Group 8.
It is found in the 2024 version of the ICD-10 Procedure Coding System (PCS) and can be used in all HIPAA-covered transactions from Oct 01, 2023 - Sep 30, 2024.
Introduction involves:
Putting in or on a therapeutic, diagnostic, nutritional, physiological, or prophylactic substance except blood or blood products.
Percutaneous approach involves:
Entry, by puncture or minor incision, of instrumentation through the skin or mucous membrane and any other body layers necessary to reach the site of the procedure
Coagulation Factor Xa, Inactivated device includes:
ICD-10-PCS code structure for XW04378
— See Table View
1: Section | X |
New Technology |
---|---|---|
2: Body System | W |
Anatomical Regions |
3: Root Operation | 0 |
Introduction |
4: Body Part | 4 |
Central Vein |
5: Approach | 3 |
Percutaneous |
6: Device | 7 |
Coagulation Factor Xa, Inactivated |
7: Qualifier | 8 |
New Technology Group 8 |
See also